MORGAN STANLEY PLC/CALL/MERCK & CO./117.5/0.1/21.06.24 | Delayed Börse Stuttgart 14:33:09 2024-05-31 EDT | ||
| 0.78 EUR | +6.85% |
|
| 1 month | -40.00% | ||
| 3 months | -35.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 0.78 | +6.85% |
| 24-05-30 | 0.73 | -10.98% |
| 24-05-29 | 0.82 | -5.75% |
| 24-05-28 | 0.87 | -23.01% |
| 24-05-27 | 1.13 | -2.59% |
Delayed Quote Börse Stuttgart
Last update May 31, 2024 at 02:33 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Morgan Stanley |
| WKN | MD7C1A |
| ISIN | DE000MD7C1A2 |
| Date issued | 2022-08-24 |
| Strike | 117.5 $ |
| Maturity | 2024-06-21 (19 Days) |
| Parity | 10 : 1 |
| Emission price | 0.49 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.61 € |
|---|---|
| Lowest since issue | 0.116 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5
USD
Average target price
141.9
USD
Spread / Average Target
+13.01%
- Stock Market
- Warrants
- Warrant
